-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, JpW+lTMHTVMY7QF8tNZkxFptGm9E5GPt7aLwb26gTzJmtr9G6LwUfO2IimNUBEkO K8k/YntosAyPOLqkG+q9FA== 0001013708-97-000003.txt : 19970109 0001013708-97-000003.hdr.sgml : 19970109 ACCESSION NUMBER: 0001013708-97-000003 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19970107 ITEM INFORMATION: Changes in control of registrant FILED AS OF DATE: 19970108 SROS: NASD FILER: COMPANY DATA: COMPANY CONFORMED NAME: MEDIZONE INTERNATIONAL INC CENTRAL INDEX KEY: 0000753772 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122] IRS NUMBER: 870412648 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 002-93277-D FILM NUMBER: 97502323 BUSINESS ADDRESS: STREET 1: 123 E 54TH ST #2H CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 2124210303 FORMER COMPANY: FORMER CONFORMED NAME: MADISON FUNDING INC DATE OF NAME CHANGE: 19860413 8-K 1 FORM 8-K (CURRENT REPORT) SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 CURRENT REPORT ON FORM 8-K Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: December 12, 1996 (Date of Earliest event reported) -------------------------------- MEDIZONE INTERNATIONAL, INC. -------------------------------- (Exact name of Registrant as specified in its charter) Nevada 2-93277-D 87-0412648 - ------------- --------------- ------------- State of Commission IRS Taxpayer Incorporation Registration No. I.D. Number 123 East 54th Street, Suite 7B, New York, New York 10022 - -------------------------------------------------------------------------------- Address of Principal executive offices Registrant's telephone number: (212) 421-0303 Item 9. Sales of Equity Securities Pursuant to Regulation S --------------------------------------------------- On December 12, 24 and 27, 1996, Medizone International, Inc. (the "Registrant") sold an aggregate of $45,000 of its securities, in units (the "Units"), each Unit consisting of 10,000 shares of the Registrant's common stock, par value $.001 (the "Common Stock"), and a warrant to purchase 20,000 shares of the Registrant's Common Stock at an exercise price of $.10 until May 31, 1997 (the "Warrant") at a per Unit price of $1,000. A total of 45 Units were sold to five individual investors, each a resident of New Zealand. The transactions were consummated directly by the Registrant pursuant to Regulation S, promulgated under the Securities Act of 1933. Each of the investors has agreed that no sale of the Common Stock contained in the Units or the Common Stock issuable upon the exercise of the Warrants may be made to a U.S. person (as such term is defined in Regulation S) for a period of two years from the date of the issuance of such security. SIGNATURES ---------- Pursuant to the requirements of the Securities Act of 1934, the Registrant has duly caused this Current Report to be signed on its behalf by the undersigned, one of its officers thereunto duly authorized. Dated: New York, New York January 7, 1997 MEDIZONE INTERNATIONAL, INC. By: s/Joseph S. Latino ------------------------- Joseph S. Latino President -----END PRIVACY-ENHANCED MESSAGE-----